Glucose-6-phosphate dehydrogenase deficiency, often called G6PD deficiency, is a lifelong inherited condition that affects red blood cells. Many people with G6PD deficiency have no day-to-day problems, but certain medicines, infections, or fava beans can trigger a sudden breakdown of red blood cells. The early symptoms of G6PD deficiency can include tiredness, pale skin, dark urine, shortness of breath, and yellowing of the eyes or skin. Not everyone will have the same experience. G6PD deficiency is often recognized in infancy, childhood, or early adulthood, and treatment focuses on avoiding triggers and treating hemolytic episodes quickly, while severe complications and death are uncommon with prompt care.
How many people live with Glucosephosphate dehydrogenase deficiency?
Glucose-6-phosphate dehydrogenase deficiency, often called G6PD deficiency, affects about 400 million people worldwide (MedlinePlus Genetics, 2024). In the United States, there is no single official national count, but commonly used prevalence figures, including about 1 in 10 African American males, suggest that at least 2 million people may be living with it rather than this being a direct head count (MedlinePlus Genetics, 2024; U.S. Census Bureau, 2023).
Overview
Glucosephosphate dehydrogenase deficiencySymptoms
Many people with glucose-6-phosphate dehydrogenase deficiency have no day-to-day symptoms. After certain medicines, infections, or fava beans, they can develop sudden tiredness, pale skin, dark urine, shortness of breath, and yellowing of the skin or eyes.
Outlook and prognosis
People with Glucosephosphate dehydrogenase deficiency usually live full, healthy lives when triggers such as certain medicines, fava beans, and infections are managed. Outlook is excellent, though some may have occasional episodes of anemia or newborn jaundice.
Causes and risk factors
Glucosephosphate dehydrogenase deficiency is caused by a change in the G6PD gene, usually inherited and more common in males. Risk is higher with family ancestry from Africa, the Mediterranean, the Middle East, or Asia. Certain medicines, infections, and fava beans can trigger problems.
Genetic influences
Genetics are central to Glucosephosphate dehydrogenase deficiency because it is usually inherited through changes in the G6PD gene, often on the X chromosome. These genetic variations strongly affect who develops symptoms and how severe episodes may be.
Diagnosis
Diagnosis of glucosephosphate dehydrogenase deficiency usually starts with symptoms and family history, then a blood test measures enzyme activity. If results are unclear, repeat testing after recovery or genetic tests can help confirm the diagnosis.
Treatment and drugs
Glucosephosphate dehydrogenase deficiency is managed by avoiding trigger drugs, fava beans, and infections when possible. Many people need no daily treatment. During a hemolytic episode, fluids, oxygen, and sometimes blood transfusions may be needed.
Symptoms
Many people with Glucosephosphate dehydrogenase deficiency, often shortened to G6PD deficiency, feel completely well most of the time. The early features of Glucosephosphate dehydrogenase deficiency usually appear only when red blood cells are stressed by an infection, certain medicines, fava beans, or chemicals such as mothballs. When that happens, red blood cells can break down too quickly, which may cause sudden anemia and jaundice. Features vary from person to person and can change over time.
Many people with G6PD deficiency have no noticeable problems between episodes. The condition is often first noticed only after a trigger causes red blood cells to break down faster than usual.
During an episode, people may feel weak, unusually tired, or washed out. Skin, lips, or the inside of the lower eyelids can also look paler than normal.
The skin or whites of the eyes may look yellow, a sign called jaundice. This happens when the body is clearing the breakdown products from damaged red blood cells.
Urine may turn tea-colored, cola-colored, or dark brown during active red blood cell breakdown. Some may notice this at the same time as tiredness or yellowing of the eyes.
How people usually first notice Glucosephosphate dehydrogenase deficiency?
How glucose-6-phosphate dehydrogenase deficiency is first noticed often depends on age: many people with this genetic condition are first recognized as newborns who develop jaundice, meaning yellowing of the skin or eyes, in the first days of life. Others are not noticed until later, when an infection, certain medicines, or fava beans trigger the rapid breakdown of red blood cells, causing the first signs of glucose-6-phosphate dehydrogenase deficiency such as unusual tiredness, pale skin, dark urine, shortness of breath, or a fast heartbeat. For many families, the clue is that these symptoms appear suddenly after a trigger, and a blood test then confirms G6PD deficiency.
Types of Glucosephosphate dehydrogenase deficiency
Glucose-6-phosphate dehydrogenase deficiency, often called G6PD deficiency, is a genetic condition with several recognized clinical variants. These variants are usually grouped by how much enzyme activity is left and how likely they are to cause red blood cell breakdown. Symptoms don’t always look the same for everyone. When people talk about the types of glucose-6-phosphate dehydrogenase deficiency, they often mean these severity classes rather than completely separate diseases.
Class I
This is the most severe form and is linked to ongoing red blood cell breakdown, even between triggers. Many living with this type can have chronic anemia, tiredness, jaundice, or an enlarged spleen. Infections or certain medicines can still cause sudden worsening.
Class II
This type causes very low enzyme activity, but red blood cells are usually stable until a trigger appears. People with Class II G6PD deficiency may feel well most of the time, then develop sudden anemia, dark urine, or yellowing of the skin and eyes after some drugs, infections, or fava beans. Episodes can be serious and may need urgent care.
Class III
This is a milder but still common variant, with low enzyme activity that usually causes problems only during stress on the body. One person might struggle mostly with episodes after a fever or infection, while another notices more symptoms after a medicine or food trigger. Between episodes, many people feel completely normal.
Class IV
This variant has near-normal enzyme activity and usually does not cause symptoms. People may never know they have it unless testing is done for family history or a routine blood workup. Hemolytic episodes are not expected in most cases.
Class V
This is a rare variant with higher-than-usual enzyme activity. It is generally not linked to illness or the typical red blood cell problems seen in G6PD deficiency. In practice, it usually does not affect day-to-day health.
Can I slow down the onset of symptoms?
No. Glucosephosphate dehydrogenase deficiency is an inherited condition you are born with, so there is no proven way to delay when it begins, but many people can lower the risk of symptom episodes by avoiding well-known triggers such as certain medicines, fava beans, and infections when possible. Good prevention planning includes telling every doctor and pharmacist about the condition before taking new medicine and getting infections treated early; in some places, newborn screening helps families find it sooner. These steps cannot prevent the condition itself, but they can often help people living with it stay well and avoid many problems.
What genetics can tell you about symptoms
In glucose-6-phosphate dehydrogenase deficiency, genetics can give some clues about symptoms, but they do not predict everything. Different gene changes can affect how much enzyme activity is left, and that can influence whether someone has no symptoms, develops mild episodes of anemia, or has more severe breakdown of red blood cells after triggers such as certain medicines, infections, or fava beans; genetics can also help explain why some newborns develop jaundice early in life. Even so, symptoms vary widely, and people with the same genetic change can have different experiences.
Causes and risk factors
Many living with G6PD deficiency feel fine most of the time, but symptoms can start suddenly after a trigger. G6PD deficiency is caused by a change in the G6PD gene, and it is usually inherited from a parent. Symptoms are more likely in people assigned male at birth because the gene sits on the X chromosome. The condition is also more common in families with African, Mediterranean, Middle Eastern, and South or Southeast Asian roots. Having a gene change doesn’t mean you’ll definitely develop the condition, but infections, fava beans, mothballs, and some medicines are common triggers for G6PD deficiency symptoms.
What are the most common causes or risk factors?
Glucose-6-phosphate dehydrogenase deficiency is almost always inherited, so the main cause is being born with a changed gene that makes red blood cells less able to handle stress. It is more common in males and in people with family roots in Africa, the Mediterranean, the Middle East, and parts of Asia, especially when a close family member has it. These things do not cause the condition itself, but infections, fava beans, mothballs, and some medicines can trigger symptoms or cause red blood cells to break down in people living with it.
Environmental and biological risk factors
When people ask about risk factors for glucose-6-phosphate dehydrogenase deficiency, most of the important ones are body-based and present before birth. Doctors often group risks into internal (biological) and external (environmental). For G6PD deficiency, environmental causes are not well established, so factors such as sex and population background matter far more.
G6PD deficiency is much more common in boys and men because of the way the condition is carried on the sex chromosomes. With only one X chromosome, a single affected copy can be enough for the condition to be present. Girls and women can also have G6PD deficiency, but it is less common.
G6PD deficiency is seen more often in people with African, Mediterranean, Middle Eastern, South Asian, or Southeast Asian background. These patterns reflect how common the condition is in different populations around the world.
Common environmental exposures during pregnancy are not a well-established cause of G6PD deficiency. For most families, the main recognized risks are biological rather than environmental.
Genetic risk factors
When people ask what causes glucosephosphate dehydrogenase deficiency, the answer is an inherited change in the G6PD gene. Because this gene sits on the X chromosome, genetic risk is not passed down in the same way for everyone. Family history and ancestry can make G6PD deficiency more likely. Carrying a genetic change doesn’t guarantee the condition will appear in the same way for everyone.
G6PD gene change: G6PD deficiency starts with a change in the G6PD gene, which lowers how well this enzyme works or how much of it the body makes. With less working enzyme, red blood cells are more vulnerable to chemical stress.
X-linked pattern: The G6PD gene sits on the X chromosome, so this condition is inherited in an X-linked pattern. A child’s chance of having glucosephosphate dehydrogenase deficiency depends on which parent passed on the changed gene.
One X chromosome: Many people assigned male at birth are more likely to have G6PD deficiency because they usually have only one X chromosome. If that single X carries the changed gene, there is no second copy to make up for it.
Two X chromosomes: People assigned female at birth may carry one changed copy and one working copy of the gene. Some have no symptoms, while others can still be affected if many of their red blood cells use the changed copy or if both X chromosomes carry a change.
Family history: G6PD deficiency often runs in families, so an affected parent, sibling, or other close relative raises the chance that the gene change is being passed along. This is one of the clearest clues when doctors look at inherited risk.
Ancestry background: Certain G6PD gene changes are more common in people with African, Mediterranean, Middle Eastern, South Asian, or Southeast Asian ancestry. People with the same risk factor can have very different experiences.
Variant type: Not all G6PD gene changes have the same effect. Some lead to very low enzyme activity, while others cause a milder shortage and a lower chance of noticeable problems.
Lifestyle risk factors
Glucosephosphate dehydrogenase deficiency is inherited, so lifestyle habits do not cause it. However, how lifestyle affects Glucosephosphate dehydrogenase deficiency can be important because certain exposures and habits can trigger oxidative stress and lead to red blood cell breakdown. The main goal is to avoid preventable triggers and reduce the chance of hemolytic episodes and related complications such as anemia, jaundice, and dark urine.
Eating fava beans is a well-known trigger that can cause sudden hemolysis in some people with Glucosephosphate dehydrogenase deficiency. Being careful with unfamiliar legumes, herbal products, or traditional remedies may also help avoid oxidant exposures that stress red blood cells.
Some over-the-counter medicines, supplements, and herbal preparations can trigger hemolysis if they have oxidant effects. Checking new products with a clinician or pharmacist is part of practical lifestyle risk factors for Glucosephosphate dehydrogenase deficiency because it can prevent avoidable attacks.
Heavy alcohol intake can increase oxidative stress and may worsen dehydration during a hemolytic episode. Limiting alcohol may help reduce strain on the body when red blood cells are already vulnerable.
Poor fluid intake does not cause the condition, but dehydration can make an acute hemolytic event harder on the body. Staying well hydrated may support circulation and help protect the kidneys if hemoglobin is released during red blood cell breakdown.
Risk prevention
For people living with glucosephosphate dehydrogenase deficiency, the main goal is not to prevent the condition itself but to prevent red blood cells from breaking down during a trigger, which can cause anemia, jaundice, dark urine, and sudden fatigue. Many with glucosephosphate dehydrogenase deficiency stay well when they avoid known triggers and get prompt care during infections or other illnesses. Prevention is flexible—it adapts to your life and health background.
The most important step is avoiding medicines and chemicals known to trigger red blood cell breakdown in glucosephosphate dehydrogenase deficiency. Ask a doctor or pharmacist to check any new prescription, over-the-counter medicine, or supplement before you take it.
Some people with glucosephosphate dehydrogenase deficiency need to avoid fava beans, which can trigger a sudden episode of anemia. If you are unsure about foods to avoid with glucosephosphate dehydrogenase deficiency, ask your care team for a clear list based on your type and history.
Infections are a common trigger for hemolysis, which is the rapid breakdown of red blood cells. Getting evaluated early for fever, cough, painful urination, or stomach illness may lower the chance of a more serious episode.
Because this condition runs in families, relatives may benefit from testing or from learning about common triggers. This can be especially helpful before a baby is born, during childhood, or before starting new medicines.
Can you prevent Glucosephosphate dehydrogenase deficiency?
No, this condition is inherited, so you cannot prevent being born with it. But many people with it can help prevent sudden problems, such as the breakdown of red blood cells, by avoiding known triggers like certain medicines, fava beans, and chemicals in mothballs, and by getting infections treated quickly. A doctor or pharmacist can help you check which medicines and products are safest for you.
Transmission
Glucose-6-phosphate dehydrogenase deficiency, often called G6PD deficiency, is not infectious, so it does not spread from person to person through touch, kissing, sex, food, or the air. Instead, it is usually passed from parent to child through genes.
To understand how G6PD deficiency is inherited, it helps to know that the changed gene is on the X chromosome. Because males have one X chromosome, they are more likely to have symptoms if they inherit the changed gene, while females may be carriers, mildly affected, or sometimes clearly affected depending on how their two X chromosomes are working. In some families, the change appears for the first time in a child because of a new genetic change, but this is less common than inheritance from a parent.
When to test your genes
Consider genetic testing for G6PD deficiency if there is a family history, newborn jaundice, unexplained anemia, or dark urine after infections, fava beans, or certain medicines. Testing can confirm the diagnosis and help guide safer medication choices and trigger avoidance, especially before drugs known to stress red blood cells.
Diagnosis
Many people with glucosephosphate dehydrogenase deficiency do not know they have it until a medicine, infection, or certain foods trigger sudden symptoms such as unusual tiredness, pale skin, shortness of breath, or dark urine. Because it is an inherited condition, diagnosis is often based on the pattern of symptoms, family background, and blood tests that show red blood cells are breaking down faster than they should. Getting a diagnosis is often a turning point toward answers and support.
Doctors ask about episodes of jaundice, dark urine, fatigue, or shortness of breath, especially after an infection, a new medicine, or fava beans. This history can provide the first clues in the diagnosis of glucosephosphate dehydrogenase deficiency.
Because this condition can run in families, your provider may ask whether relatives have had anemia, newborn jaundice, or similar reactions to medicines. Family history is often a key part of the diagnostic conversation.
A complete blood count looks for anemia and may show that red blood cell levels have dropped during or after a hemolytic episode. Doctors may also check reticulocytes, which are young red blood cells that often rise as the body tries to replace cells it has lost.
Blood and urine tests can show signs that red blood cells are being destroyed, including higher bilirubin and lactate dehydrogenase and lower haptoglobin. These results help confirm that symptoms are due to hemolysis rather than another common cause of anemia.
How is Glucosephosphate dehydrogenase deficiency diagnosed?
Doctors usually diagnose glucose-6-phosphate dehydrogenase, or G6PD, deficiency with a blood test that measures how much of this protective substance is in red blood cells, the cells that carry oxygen around the body. They may also look at symptoms, family history, and signs that red blood cells are breaking down, especially after certain medicines, foods, or infections. Sometimes the first test can miss it during or soon after a reaction, so the test may need to be repeated later, and genetic testing is sometimes used to confirm the diagnosis or check other family members.
Stages of Glucosephosphate dehydrogenase deficiency
Glucosephosphate dehydrogenase deficiency does not have defined progression stages. This is because it usually does not steadily worsen over time; instead, people may stay well between episodes and then develop symptoms when something triggers red blood cell breakdown, such as certain medicines, infections, or fava beans. Doctors usually start with a conversation about symptoms, recent illnesses, medicines, foods, and family history, especially if there have been episodes of jaundice, dark urine, tiredness, or other early symptoms of Glucosephosphate dehydrogenase deficiency. It is usually diagnosed with a blood test that measures enzyme activity, and follow-up focuses on avoiding triggers and checking blood counts during or after a hemolytic episode.
Outlook and prognosis
The outlook for people with glucose-6-phosphate dehydrogenase deficiency is generally very good, especially when known triggers such as certain medications, infections, and fava beans are avoided. Most affected individuals have a normal life expectancy and remain well between episodes, although some may have recurrent hemolytic anemia after exposures. Hemolytic crises are usually self-limited once the trigger is removed, but severe episodes can cause jaundice, profound anemia, and rarely kidney injury requiring urgent treatment. Newborns with this condition need careful monitoring because severe neonatal jaundice can lead to kernicterus and permanent neurologic damage if not recognized and treated promptly. Mortality is uncommon in settings with good medical care, but it can occur in untreated severe hemolysis or severe neonatal hyperbilirubinemia.
Long-term effects
For many people, glucosephosphate dehydrogenase deficiency has little day-to-day impact until the body is stressed by an infection, certain medicines, or other triggers that can damage red blood cells. Long-term effects vary widely, from no lasting problems to repeated episodes of anemia over time. Most people do not develop constant symptoms between episodes, but some may have recurring health effects that matter more in infancy, during infections, or later in life if episodes are frequent.
The main long-term issue is repeated episodes of red blood cell breakdown, which can cause sudden tiredness, shortness of breath, fast heartbeat, dark urine, and yellowing of the eyes or skin. For many living with glucosephosphate dehydrogenase deficiency, these episodes are separated by long stretches of feeling well.
When red blood cells break down faster than the body can replace them, anemia can develop and may come back with different triggers over the years. Some effects may be mild and short-lived, while others can be severe enough to need urgent medical care.
In babies, glucosephosphate dehydrogenase deficiency can lead to significant jaundice soon after birth, and this is one of the most important early symptoms of glucosephosphate dehydrogenase deficiency to recognize. If bilirubin levels rise very high and are not treated quickly, there can be a risk of brain injury and long-term developmental problems.
Repeated blood cell breakdown over many years can raise the chance of pigment gallstones in some people. These may cause belly pain, nausea, or inflammation of the gallbladder later in childhood or adulthood.
How is it to live with Glucosephosphate dehydrogenase deficiency?
For many people living with glucose-6-phosphate dehydrogenase deficiency, daily life is mostly normal until a trigger appears, such as certain medicines, fava beans, or an infection, which can suddenly make red blood cells break down faster than the body can replace them. That can lead to tiredness, shortness of breath, yellowing of the eyes or skin, dark urine, and the need to rest or get medical care, so a big part of living well with the condition is learning what to avoid and making sure healthcare teams know about it. Family members and close friends are often affected in practical ways too, because they may help watch for warning signs, check medicines, and plan around known triggers, but with good awareness, many people with this condition live full and active lives.
Treatment and drugs
For many living with Glucosephosphate dehydrogenase deficiency, treatment is mostly about preventing episodes of sudden red blood cell breakdown that can lead to tiredness, shortness of breath, dark urine, or jaundice after certain medicines, infections, or foods. The main approach is avoiding known triggers, treating infections promptly, and checking with a doctor or pharmacist before starting new medicines, since there is no routine drug that fixes the enzyme problem itself. During a flare, care may include fluids, oxygen, and close monitoring, and some people with more severe anemia may need a blood transfusion. Supportive care can make a real difference in how you feel day to day, and if you are wondering about the best treatment for Glucosephosphate dehydrogenase deficiency, your doctor can help you build a clear list of medicines and foods to avoid.
Can you cure Glucosephosphate dehydrogenase deficiency?
No, there is no cure for glucosephosphate dehydrogenase deficiency, because it is an inherited condition that affects how red blood cells handle stress. Treatment focuses on prevention and symptom control, which usually means avoiding triggers such as certain medicines, infections, and fava beans. If red blood cells break down quickly and cause a severe episode, doctors can treat the problem with supportive care and, in some cases, a blood transfusion.
Non-drug treatment
Daily care for glucosephosphate dehydrogenase deficiency, often called G6PD deficiency, is mostly about preventing red blood cells from being damaged in the first place. Managing this condition often means learning your personal triggers, planning ahead for illness, and getting quick medical care if symptoms of red blood cell breakdown appear. For many, this can mean carrying a list of unsafe medicines and foods, since avoiding triggers is the main non-drug treatment for G6PD deficiency.
The most important step is staying away from things that can trigger red blood cell breakdown, including certain medicines, fava beans, and chemicals such as mothballs. Learning the main foods to avoid with G6PD deficiency and checking medicines before taking them can help prevent sudden episodes.
Infections are a common trigger, so reducing exposure to illness and treating infections promptly can lower the risk of a flare. Simple routines—like handwashing or keeping up with recommended vaccines—can have lasting benefits.
Wearing a medical alert bracelet or keeping a wallet card can help emergency teams avoid unsafe medicines. This is especially helpful if you are too unwell to explain that you have G6PD deficiency.
During a mild episode, drinking enough fluids and resting can support recovery while the body clears damaged red blood cells. If urine turns very dark, weakness is severe, or breathing feels hard, medical care is needed right away.
Your genes may have an impact on how drugs work for you
For people with glucose-6-phosphate dehydrogenase deficiency, certain medicines can stress red blood cells and cause them to break down too quickly, which can lead to sudden tiredness, shortness of breath, dark urine, or yellowing of the skin or eyes. This happens because of an inherited difference in how the body protects red blood cells, so common medicines that are safe for many others, including some antibiotics and malaria drugs, may not be safe here. In this condition, using genetic information to guide medicine choices is clearly relevant, so it helps to tell every doctor and pharmacist about the condition before starting anything new, even over-the-counter drugs.
Pharmacological treatments
For many, treatment for G6PD deficiency in adults is mostly about avoiding trigger medicines and using supportive care during red blood cell breakdown episodes. There is no drug that replaces the missing enzyme or cures glucosephosphate dehydrogenase deficiency. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy). When treatment is needed, it is usually aimed at complications such as infection or ongoing anemia rather than the enzyme problem itself.
There is no approved medicine that restores G6PD enzyme activity in red blood cells. For people with glucosephosphate dehydrogenase deficiency, the main medical step is avoiding drugs known to trigger hemolysis, such as primaquine, tafenoquine, dapsone, rasburicase, and sulfonamide antibiotics.
Folic acid may be prescribed for some people who have repeated or ongoing hemolysis. It helps the body make new red blood cells, so it can support recovery from anemia but does not treat the underlying enzyme deficiency.
Infections can trigger hemolysis in G6PD deficiency, so antibiotics may be used when a bacterial infection is present. Doctors usually choose options considered safer for G6PD deficiency and avoid higher-risk drugs such as sulfamethoxazole-containing antibiotics when possible.
If malaria prevention or treatment is needed, the drug choice matters because some antimalarials can cause severe hemolysis in people with glucosephosphate dehydrogenase deficiency. Primaquine and tafenoquine are usually avoided unless careful testing and specialist guidance show they can be used safely.
Genetic influences
For many living with glucose-6-phosphate dehydrogenase deficiency, often called G6PD deficiency, the reason it runs in families is a change in the G6PD gene on the X chromosome. Because of this X-linked pattern, G6PD deficiency is more common in males, but females can be carriers and may also have mild to significant symptoms. The gene change is present from birth, yet many people with G6PD deficiency feel well unless their red blood cells are stressed by certain medicines, infections, or foods such as fava beans. Severity can vary, even within the same family, so one relative may have only mild episodes while another has clearer early symptoms of G6PD deficiency. Understanding whether a condition is inherited can guide next steps, including family testing or genetic counseling when it is needed. Knowing the genetic cause of G6PD deficiency can help families avoid triggers and make safer treatment choices.
Is Glucosephosphate dehydrogenase deficiency genetic?
Genetics are central to Glucosephosphate dehydrogenase deficiency because it is usually inherited through changes in the G6PD gene, often on the X chromosome. These genetic variations strongly affect who develops symptoms and how severe episodes may be.
Having a genetic risk is not necessarily a diagnosis
Genetic changes are a normal part of human biology and are common across the general population. Most do not have a direct effect on health and are simply part of natural human diversity. For many genes, having a variant linked to a condition points to a possible association, not a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many people with G6PD deficiency, treatment is less about taking a daily medicine and more about avoiding drugs that can suddenly trigger red blood cell breakdown, leading to fatigue, jaundice, or dark urine. This happens because changes in the G6PD gene affect how well red blood cells handle certain chemical stresses, and some gene variants leave more enzyme activity than others. Not every difference in response is genetic, but with G6PD deficiency, the exact gene change can help estimate how sensitive someone may be to specific medicines. Drugs doctors are especially careful with in G6PD deficiency include rasburicase, primaquine and related antimalarials, dapsone, and some sulfa antibiotics, so safer alternatives are often chosen when possible. Many living with G6PD deficiency also ask about medications to avoid with G6PD deficiency before starting a new prescription, because risk can vary with the drug, the dose, and the person’s remaining enzyme activity. In some women and girls, enzyme levels can be harder to predict, so doctors may use both lab testing and a careful medication history when deciding which treatments are safest.
Interactions with other conditions
For many living with Glucosephosphate dehydrogenase deficiency, other illnesses matter most when they put the body under stress, especially infections such as pneumonia, hepatitis, or a bad flu-like illness. During these times, red blood cells can break down faster than usual, so someone might notice sudden tiredness, shortness of breath, dark urine, or yellowing of the eyes while they are already dealing with another disease. Doctors call it a comorbidity when two conditions occur together. In Glucosephosphate dehydrogenase deficiency, that overlap is especially important with illnesses that cause inflammation, fever, or liver strain, because they can make a hemolytic episode more likely. Newborn jaundice also needs closer attention if a baby has Glucosephosphate dehydrogenase deficiency, since conditions like prematurity, dehydration, or infection can raise the risk of bilirubin building up too high. People with Glucosephosphate dehydrogenase deficiency should also let their care team know about any kidney, liver, or blood disorders, because these can complicate recovery and make it harder to tell what is causing anemia symptoms.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Glucosephosphate dehydrogenase deficiency?
Other inherited blood conditions, especially sickle cell disease, thalassemia, and hereditary spherocytosis, can cause similar problems such as tiredness, pale skin, yellowing of the skin or eyes, and dark urine. Autoimmune hemolytic anemia, which means the body is mistakenly breaking down its own red blood cells, can also look very similar, and some liver illnesses such as hepatitis can also cause jaundice. Doctors usually sort these apart with blood tests and by asking about triggers like infections, certain medicines, or fava beans.
History
Long before blood tests were available, doctors noticed that some otherwise healthy people became suddenly pale, deeply tired, or yellow-eyed after certain illnesses, foods, or medicines. What we now call glucose-6-phosphate dehydrogenase deficiency was first recognized through these patterns, especially when episodes of anemia seemed to come and go rather than stay constant. In everyday life, this could look like someone recovering from an infection and then, within a day or two, becoming weak, short of breath, and unusually dark in their urine.
By the early 20th century, researchers began linking these episodes to the way red blood cells handle stress. In the 1950s, the condition came into sharper focus when some people developed severe breakdown of red blood cells after taking certain antimalarial drugs, which pushed scientists to look for an underlying enzyme problem. From these first observations, doctors learned that glucose-6-phosphate dehydrogenase deficiency is not an infection or a form of cancer, but a lifelong trait that affects how well red blood cells cope with oxidative stress.
As laboratory medicine improved, testing made it possible to identify the enzyme deficiency directly, even in people who felt well most of the time. This helped explain why the condition appears in many parts of the world and why symptoms can vary so much, from no noticeable problems to episodes of jaundice or anemia triggered by illness, certain drugs, or fava beans. In recent decades, awareness has grown, and that has made early symptoms of glucose-6-phosphate dehydrogenase deficiency easier to recognize and avoid. Researchers later identified a genetic cause, but the biggest shift for many families came from something practical: knowing the diagnosis meant learning which triggers to avoid and when to seek help quickly.